Literature DB >> 24838262

Staphylococcal superantigens interact with multiple host receptors to cause serious diseases.

Christopher S Stach1, Alfa Herrera, Patrick M Schlievert.   

Abstract

Staphylococcus aureus strains that cause human diseases produce a large family of pyrogenic toxin superantigens (SAgs). These include toxic shock syndrome toxin-1 (TSST-1), the staphylococcal enterotoxins (SEs), and the SE-like proteins; to date, 23 staphylococcal SAgs have been described. Among the SAgs, three have been highly associated with human diseases (TSST-1, SEB, and SEC), likely because they are produced in high concentrations compared to other SAgs. Another major family of exotoxins produced by S. aureus is the cytolysins, particularly α-, β-, γ-, and δ-toxins, phenol soluble modulins, and leukocidins. This review discusses the association of SAgs with human diseases and particularly the "outside-in" signaling mechanism that leads to SAg-associated diseases. We discuss SAg interactions with three host immune cell receptors, including variable regions of the β-chain of the T cell receptor, MHC II α- and/or β-chains, and an epithelial/endothelial cell receptor that may include CD40. To a lesser extent, we discuss the role of cytolysins in facilitating disease production by SAgs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24838262      PMCID: PMC4125451          DOI: 10.1007/s12026-014-8539-7

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  39 in total

1.  Structure and biological activities of beta toxin from Staphylococcus aureus.

Authors:  Medora Huseby; Ke Shi; C Kent Brown; Jeff Digre; Fikre Mengistu; Keun Seok Seo; Gregory A Bohach; Patrick M Schlievert; Douglas H Ohlendorf; Cathleen A Earhart
Journal:  J Bacteriol       Date:  2007-09-14       Impact factor: 3.490

Review 2.  Staphylococcus aureus infections.

Authors:  F D Lowy
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

3.  Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.

Authors:  Jeffrey Parsonnet; Melanie A Hansmann; Mary L Delaney; Paul A Modern; Andrea M Dubois; Wendy Wieland-Alter; Kimberly W Wissemann; John E Wild; Michaelle B Jones; Jon L Seymour; Andrew B Onderdonk
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 4.  The structural basis of T cell activation by superantigens.

Authors:  H Li; A Llera; E L Malchiodi; R A Mariuzza
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 5.  Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.

Authors:  G A Bohach; D J Fast; R D Nelson; P M Schlievert
Journal:  Crit Rev Microbiol       Date:  1990       Impact factor: 7.624

6.  The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1.

Authors:  Marnie L Peterson; Kevin Ault; Mary J Kremer; Aloysius J Klingelhutz; Catherine C Davis; Christopher A Squier; Patrick M Schlievert
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 7.  Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope.

Authors:  W W Navarre; O Schneewind
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

Review 8.  Superantigens and their potential role in human disease.

Authors:  B L Kotzin; D Y Leung; J Kappler; P Marrack
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

9.  Alpha and beta chains of hemoglobin inhibit production of Staphylococcus aureus exotoxins.

Authors:  Patrick M Schlievert; Laura C Case; Kimberly A Nemeth; Catherine C Davis; Yiping Sun; Wendy Qin; Fancheng Wang; Amanda J Brosnahan; John A Mleziva; Marnie L Peterson; Bruce E Jones
Journal:  Biochemistry       Date:  2007-11-20       Impact factor: 3.162

10.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States.

Authors:  R Monina Klevens; Melissa A Morrison; Joelle Nadle; Susan Petit; Ken Gershman; Susan Ray; Lee H Harrison; Ruth Lynfield; Ghinwa Dumyati; John M Townes; Allen S Craig; Elizabeth R Zell; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; Scott K Fridkin
Journal:  JAMA       Date:  2007-10-17       Impact factor: 56.272

View more
  26 in total

Review 1.  Staphylococcal manipulation of host immune responses.

Authors:  Vilasack Thammavongsa; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Nat Rev Microbiol       Date:  2015-09       Impact factor: 60.633

2.  Bacterial Superantigens Expand and Activate, Rather than Delete or Incapacitate, Preexisting Antigen-Specific Memory CD8+ T Cells.

Authors:  Courtney E Meilleur; Christine M Wardell; Tina S Mele; Jimmy D Dikeakos; Jack R Bennink; Hong-Hua Mu; John K McCormick; S M Mansour Haeryfar
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

3.  Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity.

Authors:  Alyssa R Martin; Ross A Pollack; Adam Capoferri; Richard F Ambinder; Christine M Durand; Robert F Siliciano
Journal:  J Clin Invest       Date:  2017-01-17       Impact factor: 14.808

4.  Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.

Authors:  Krisana Asano; Kouji Narita; Shouhei Hirose; Akio Nakane
Journal:  Med Microbiol Immunol       Date:  2018-07-06       Impact factor: 3.402

Review 5.  Investigational drugs to treat methicillin-resistant Staphylococcus aureus.

Authors:  Cuong Vuong; Anthony J Yeh; Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Investig Drugs       Date:  2015-11-04       Impact factor: 6.206

6.  Healthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Fatal Pneumonia with Pediatric Deaths in Krasnoyarsk, Siberian Russia: Unique MRSA's Multiple Virulence Factors, Genome, and Stepwise Evolution.

Authors:  Olga E Khokhlova; Wei-Chun Hung; Tsai-Wen Wan; Yasuhisa Iwao; Tomomi Takano; Wataru Higuchi; Svetlana V Yachenko; Olga V Teplyakova; Vera V Kamshilova; Yuri V Kotlovsky; Akihito Nishiyama; Ivan V Reva; Sergey V Sidorenko; Olga V Peryanova; Galina V Reva; Lee-Jene Teng; Alla B Salmina; Tatsuo Yamamoto
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

Review 7.  A common immunopathogenesis mechanism for infectious diseases: the protein-homeostasis-system hypothesis.

Authors:  Kyung-Yil Lee
Journal:  Infect Chemother       Date:  2015-03-30

8.  Assay of Blood and Synovial Fluid of Patients With Rheumatoid Arthritis for Staphylococcus aureus Enterotoxin D: Absence of Bacteria But Presence of Its Toxin.

Authors:  Ramezan Ali Ataee; Reyhane Kashefi; Gholam Hossein Alishiri; Davoud Esmaieli
Journal:  Jundishapur J Microbiol       Date:  2015-12-26       Impact factor: 0.747

9.  Re-analysis of metagenomic sequences from acute flaccid myelitis patients reveals alternatives to enterovirus D68 infection.

Authors:  Florian P Breitwieser; Carlos A Pardo; Steven L Salzberg
Journal:  F1000Res       Date:  2015-07-02

Review 10.  Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy.

Authors:  Cin Kong; Hui-min Neoh; Sheila Nathan
Journal:  Toxins (Basel)       Date:  2016-03-15       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.